Roivant Sciences (ROIV) Assets Average (2021 - 2026)
Roivant Sciences (ROIV) posted Assets Average of $5.5 billion for Q1 2026, up 6.28% on a QoQ basis from $5.1 billion in Q4 2025, and down 2.63% year-over-year from $5.6 billion in Q1 2025.
Roivant Sciences (ROIV) Assets Average (2021 - 2026) Analysis & Trends
Roivant Sciences' Assets Average history runs 6 years deep, the most recent figure standing at $5.5 billion for Q1 2026.
- Quarterly Assets Average fell 2.63% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (down 2.63% YoY) and the FY2026 annual result came in at $5.5 billion, down 2.63% from the prior year.
- Assets Average was $5.5 billion for Q1 2026 at Roivant Sciences, up from $5.1 billion in the prior quarter.
- Across five years, Assets Average topped out at $7.3 billion in Q1 2024 and bottomed at $2.1 billion in Q3 2023.
- A 5-year average of $4.4 billion and a median of $5.0 billion in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average retreated 25.14% — and 2024, when it soared 216.49%.
- Roivant Sciences' Assets Average stood at $2.2 billion in 2022, then jumped by 112.25% to $4.7 billion in 2023, then climbed by 27.94% to $6.0 billion in 2024, then decreased by 14.26% to $5.1 billion in 2025, then rose by 6.28% to $5.5 billion in 2026.
- Business Quant data shows ROIV's Assets Average at $5.5 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | 5.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Bn |
| Dec 31, 2025 | 5.14 Bn |
| Sep 30, 2025 | 5.05 Bn |
| Jun 30, 2025 | 5.23 Bn |
| Mar 31, 2025 | 5.61 Bn |
| Dec 31, 2024 | 6.00 Bn |
| Sep 30, 2024 | 6.35 Bn |
| Jun 30, 2024 | 6.86 Bn |
| Mar 31, 2024 | 7.27 Bn |
| Dec 31, 2023 | 4.69 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 2.26 Bn |
| Mar 31, 2023 | 2.30 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 2.69 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 2.78 Bn |
| Jun 30, 2021 | 2.52 Bn |